Press release
Personal Care
February 13, 2017

Acquisition expands Evonik’s product and technology portfolio for the cosmetics industry

Essen. Evonik’s acquisition of the Air Products specialty additives business also benefits the cosmetics business of the German specialty chemicals company. “We are adding interesting products to our actives and polymer portfolio for the cosmetics industry along with a highly attractive formulation technology,” says Dr. Tammo Boinowitz, head of the Personal Care Business Line at Evonik.

The proprietary know-how of the former Air Products Schlüchtern GmbH includes a number of innovative encapsulation technologies for active cosmetic ingredients and multifunctional polymers. Using a variety of membrane-forming lipids, the active ingredients can be packaged into tiny vesicles, which serve as protective transport aids. “They enable us to deliver active ingredients specifically to the desired action site in the skin to improve the bioavailability of active ingredients and modulate their release. That also has additional positive effects, such as the stabilization of sensitive cosmetic ingredients” explains Michael Sacher, head of Personal Care Delivery Systems.

These technologies open up many new opportunities for innovative product development at Evonik. “It is conceivable, for example, to deliver innovative actives from the Evonik portfolio to deeper skin layers to enhance their efficacy,” says Sacher.

Thanks to the newly added polymers, Evonik is also moving into the field of hairstyling. “The acquisition is another step toward the goal of becoming the leading specialty provider for cosmetic ingredients,” notes Boinowitz.

Evonik will for the first time be represented at in-cosmetics 2017 with two stands. Stand N70 will exclusively present the company’s actives portfolio, while the other stand, NN30, will share customer information about the Evonik specialties portfolio.

Company information

Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals, operating in the Nutrition & Care, Resource Efficiency and Performance Materials segments. The company benefits from its innovative prowess and integrated technology platforms. In 2015 more than 33,500 employees generated sales of around €13.5 billion and an operating profit (adjusted EBITDA) of about €2.47 billion.

About Nutrition & Care

The Nutrition & Care segment is led by Evonik Nutrition & Care GmbH and contributes to fulfilling basic human needs. That includes applications for everyday consumer goods as well as animal nutrition and health care. This segment employed about 7,000 employees, and generated sales of around
€4.9 billion in 2015


In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.